Compare Fubotv Inc (FUBO) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Fubotv Inc vs Eli Lilly And Co — how do they compare? Fubotv Inc trades at $9.7 (market cap $1.06B), while Eli Lilly And Co trades at $1,218.09 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 1018.9× Fubotv Inc's market cap, and Eli Lilly And Co pays a 0.57% dividend while Fubotv Inc pays none. Which is the better fit depends on your goals.
| FUBO | LLY | |
|---|---|---|
Market Cap | $1.06B | $1.08T |
Sector | Technology | Health |
52-Week High | $54.72 | $1.24K |
52-Week Low | $8.09 | $639.43 |
Enterprise Value | $1.23B | $1.13T |
Dividend Yield | — | 0.57% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FUBO trades at $9.36, up 1.08% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with revenue growing to $1.62B in 2024 and projected net income turning positive at $123M for 2025. Recent CEO transition to former Disney executive Alisa Bowen and partnerships with major media companies signal strategic repositioning.
While valuation metrics appear attractive with P/E of 2.53 and P/S of 0.19, the stock faces execution risks in achieving profitability targets. Analyst consensus is mixed with 46.7% buy ratings and $15.33 price target, representing significant upside potential if the company can deliver on its EBITDA growth roadmap.
Eli Lilly (LLY) trades at $1,231.58, up 3.87% in the past 24 hours, reflecting strong momentum near its 52-week high. The stock exhibits bullish technical signals with robust fundamentals, including 48% revenue growth in Q2 2026 and a net income margin of 33.53%. Recent news highlights legal actions against black-market drug sales and positive analyst sentiment following earnings beats.
Outlook remains positive with a consensus price target of $1,380, though high valuation ratios (P/E 40.79) and regulatory risks pose challenges. Earnings growth and pipeline advancements, like retatrutide, drive upside potential, but investors should monitor competitive pressures and execution risks.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Fubotv Inc
FuboTV Inc is a sports-first, live TV streaming company, offering subscribers access to tens of thousands of live sporting events annually as well as news and entertainment content. Its platform, fuboTV, allows customers to access content through streaming devices and on SmartTVs, mobile phones, tablets, and computers. The company offer subscribers a live TV streaming service with the option to purchase incremental features available for purchase that include additional content or enhanced functionality best suited to their preferences. The operating segments of the group are Streaming and Online wagering, of which a majority of revenue is derived from the Streaming segment. It has a business presence in the U.S. and other international countries.
Read more on FUBO →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
